Crystal Crop Protection Limited, a prominent player in India’s agrochemical and seed sector, has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), signaling plans for an initial public offering (IPO). The move comes amid favorable structural trends in India’s agri-input market, driven by food security priorities, export potential, and growing adoption of high-yield crop solutions.
Founded in 1994, Crystal Crop has transformed from a formulation-focused agrochemical company into a fully integrated crop solutions platform, offering crop protection products, natural crop solutions, and seeds. The company leverages in-house R&D, backward-integrated manufacturing, and a nationwide distribution network to support its operations.
IPO Structure
The proposed IPO will comprise:
- Fresh issue of INR 600 crore
- Offer for Sale (OFS) of up to 74.1 lakh equity shares by promoters and investor shareholders, including IFC and IFC Emerging Asia Fund
Proceeds from the fresh issue are largely earmarked for deleveraging, with INR 422.86 crore for parent company debt repayment and INR 42.70 crore for subsidiary Saffire Crop Science. Remaining funds will support inorganic growth, strategic initiatives, and general corporate purposes.
Business Overview
Crop Protection & Natural Solutions: This segment generates over 80% of FY25 revenues, spanning herbicides, fungicides, insecticides, combination products, and a growing portfolio of biologicals and biostimulants. Crystal Crop operates 174+ branded products with a two-brand strategy (Crystal and Saffire) targeting distinct farmer segments. The business has grown at 18% CAGR between FY23–FY25, outperforming the industry average of 10–13%.
Seeds Business: Though smaller in revenue contribution, seeds represent a high-growth vertical, delivering 24.88% CAGR (FY23–FY25). Crystal Crop holds market leadership in pearl millet (20.6%) and mustard (6.3%), and has expanded its flower seed portfolio through the acquisition of I&B Seeds. The company exports to Japan, the US, Bangladesh, Nepal, and Thailand.
R&D and Manufacturing
Crystal Crop boasts a GLP-certified R&D center, 28 global patent filings (18 granted in India), and 11 commercialized patents. Manufacturing includes four formulation units (~76,000 MT capacity), two technical-grade units, and a technical pilot plant, with plans for a new automated facility in Gujarat. This backward integration enhances cost efficiency and margin expansion.
Financial Snapshot (INR Crore, FY25)
- Revenue: 2,690.51
- EBITDA: 3,152.76 (11.72% margin)
- PAT: 118.39
- EPS: 9.37
Outlook
Led by founders Nand Kishore Aggarwal and Ankur Aggarwal, Crystal Crop’s IPO aims to strengthen its financial position, support growth in seeds and biologicals, and capitalize on its brand and R&D-driven differentiation. While sector risks—monsoon variability, regulatory changes, and raw material volatility—remain, the company’s integrated model positions it for sustainable growth and enhanced return on equity post-listing.
By
